Extended Data Fig. 2: Quality of the CD19-CAR T-cell product at first and at second administration following cryopreservation.
The purity (% CD3+ of CD45+), viability (% of CD3+) and CAR+ (% of CD3+) in the product was assessed by flow cytometry.
Extended Data Fig. 2: Quality of the CD19-CAR T-cell product at first and at second administration following cryopreservation. | Nature Medicine
